|
News For ZTS;PFE From The Last 14 Days Check below for free stories on ZTS;PFE the last two weeks. |
|
|
| June 18, 2013 |
| 09:38 EDT |  | PFE | Active equity option families trading on open
Active equity option families trading on open according to Track Data: AAPL NFLX GOOG PFE TSLA MGM |
|
| 08:36 EDT |  | ZTS | Elan shares could be worh $19 in a buyout, says Jefferies
Jefferies raised its price target for shares of Elan (ELN) to $19 from $14, reflecting what it sees as the value of the company in a takeout scenario. The firm says Elan management suggested they would be open to sale in the $15-$20 per share range. Jefferies believes a high taxpaying suitor could pay the upper end of that range, and lists Allergan (AGN), Regeneron (REGN), Vertex (VRTX), Alexion (ALXN), Zoetis (ZTS), Mylan (MYL) and Perrigo (PRGO) as potential acquirers for Elan. Shares of Elan are up 13c to $13.62 in pre-market trading after Royalty Pharma announced that its buyout proposal for the company has expired. |
|
| June 17, 2013 |
| 16:00 EDT | | PFE | Options Update; June 17, 2013
 Subscribe for More Information |
|
| 08:36 EDT |  | PFE | InSite Vision to join Merck, Pfizer patent suit against Mylan
InSite Vision (INSV) announced that it will join Merck (MRK) and Pfizer (PFE) in filing a patent infringement lawsuit against Mylan Pharmaceuticals (MYL). Mylan recently filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking to market a generic version of AzaSite before expiration of the patents covering AzaSite and its use. AzaSite is marketed by Merck in the U.S. On May 26, 2011, InSite and Merck filed a similar patent infringement lawsuit against Sandoz. A trial date for the Sandoz ANDA suit has been set for July 11, 2013. The companies have agreed that Merck will take the lead in prosecuting both lawsuits. Each company will be responsible for their own legal costs, with InSite assuming a monitoring role, the company said. |
|
| 07:28 EDT |  | PFE | Cambridge Healthtech Institute to host a conference
Subscribe for More Information |
|
| June 14, 2013 |
| 17:22 EDT | | ZTS | Zoetis to be added to S&P 500; First Horizon deleted as of 6/21 close
|
|
| 16:00 EDT | | PFE | Options Update; June 14, 2013
Subscribe for More Information |
|
| 06:45 EDT | | PFE, ZTS | Zoetis volatility elevated into Pfizer split-off
Subscribe for More Information |
|
| 06:23 EDT | | ZTS | Zoetis implied volatility at upper end of index mean range
Subscribe for More Information |
|
| June 13, 2013 |
| 16:00 EDT | | PFE | Options Update; June 13, 2013
Subscribe for More Information |
| |
| 07:32 EDT | | PFE | European League Against Rheumatism to host annual meeting
Subscribe for More Information |
|
| June 12, 2013 |
| 16:02 EDT | | PFE | Options Update; June 12, 2013
Subscribe for More Information |
|
| 13:31 EDT | | PFE | Mylan could be interested in generic assets split from Pfizer, Bloomberg says
|
|
| 08:28 EDT | | PFE | Teva to pay $1.6B to settle with Pfizer, Nycomed over generic Protonix
Subscribe for More Information |
|
| 08:02 EDT | | PFE | Pfizer wins $2.15B settlement from Teva and Sun for patent infringement
Subscribe for More Information |
|
| June 11, 2013 |
| 16:00 EDT | | PFE | Options Update; June 11, 2013
Subscribe for More Information |
|
| 15:15 EDT | | PFE | Pfizer June volatility at one-year high
Subscribe for More Information |
|
| 07:42 EDT | | PFE | Boston Biotech Conferences to host a conference
Subscribe for More Information |
|
| 06:07 EDT | | ZTS | Zoetis implied volatility at upper end of index mean range
Subscribe for More Information |
|
| June 10, 2013 |
| 07:40 EDT | | PFE | Leerink's biotech analyst holds analyst/industry conference call on ASCO
Subscribe for More Information |
| |
|
|
|
|
